Oxford Nanopore raises £40m
This article was originally published in Clinica
Executive Summary
Oxford Nanopore Technologies, the UK-based technology company specializing in nanopore-based next-generation genome sequencing, has raised £40m ($63.8m) in new funding through a private placement of ordinary shares.